ANIK
Anika Therapeutics Inc
Price:  
17.84 
USD
Volume:  
45,547.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika WACC - Weighted Average Cost of Capital

The WACC of Anika Therapeutics Inc (ANIK) is 5.7%.

The Cost of Equity of Anika Therapeutics Inc (ANIK) is 7.50%.
The Cost of Debt of Anika Therapeutics Inc (ANIK) is 5.00%.

Range Selected
Cost of equity 5.50% - 9.50% 7.50%
Tax rate 18.90% - 22.40% 20.65%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.8% - 6.7% 5.7%
WACC

Anika WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.36 0.82
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 9.50%
Tax rate 18.90% 22.40%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.8% 6.7%
Selected WACC 5.7%